ČESKÁ UROLOGIE / CZECH UROLOGY – 4 / 2018

264 Ces Urol 2018; 22(4): 257–265 ORIGINÁLNÍ PRÁCE 11. Dolejšová O, Eret V, Šobrová A, et al. Využití multiparametrické magnetické rezonance a srovnání s ostatními moderními zobrazovacími metodami v předoperační diagnostice karcinomu prostaty. Ces Urol 2014; 18(4): 300–309. 12. Ferda J, Hora M, Hes O, et al. Zobrazení prostaty na 3 T MRI u nemocných se zvýšenou hladinou PSA. Ces Radiol 2012; 66(1): 9–17. 13. Kongnyuy M, George AK, Rastinehad AR, Pinto PA. Magnetic resonance imaging‑ultrasound fusion‑guided prostate biopsy: Review of technology, techniques, and outcomes. Curr Urol Rep 2016; 17: 32. 14. Ukimura O, Desai MM, Palmer S, et al. 3-Dimensional elastic registration system of prostate biopsy location by real‑time 3-dimensional transrectal ultrasound guidance with magnetic resonance/transrectal ultrasound image fusion. J Urol 2012; 187(3): 1080–1086. 15. Barentsz OJ, Richenberg J, Clements R, et al. ESUR prostate MR guidelines 2012. Eur Radiol. 2012; 22: 746–757. 16. Rosenkrantz AB, Kim S, Lim RP, et al. Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI‑RADS) and Likert scales. Radiology 2013; 269(2): 482–492. 17. Moore CM, Kasivisvanathan V, Eggener S, et al. Standards of reporting for MRI‑targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. Eur Urol 2013; 64: 544–552. 18. Šobrová E, Eret V, Dolejšová O, et al. Komparace multiparametrické magnetické rezonance se silou mag‑ netického pole 3 Tesla s transrektální sonografií naváděnou biopsií prostaty. Ces Urol 2014; 18(3): 225–233. 19. Ukimura O, Hung AJ, Gill IS. Innovations in prostate biopsy strategies for active surveillance and focal therapy. Curr Opin Urol. 2011; 21: 115–120. 20. Ghilezan MJ, Jaffray DA, Siewerdsen JH, et al. Prostate gland motion assessed with cine‑magnetic resonance imaging (cine‑MRI) Int J Radiat Oncol Biol Phys. 2005; 62: 406–417. 21. Baumann M, Mozer P, Daanen V, Troccaz J. Prostate biopsy tracking with deformation estimation. Med Image Anal. 2012; 16: 562–576. 22. Siddiqui MM, Rais‑Bahrami S, Turkbey B, et al. Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 2015; 313(4): 390–397. 23. Puech P, Rouvière O, Renard‑Penna R, et al. Prostate cancer diagnosis: multiparametric MR‑targeted biopsy with cognitive and transrectal US‑MR fusion guidance versus systematic biopsy – prospective multicenter study. Radiology. 2013; 268: 461–469. 24. Borkowetz A, Platzek I, TomaM, et al. Comparison of systematic transrectal biopsy to transperineal mag‑ netic resonance imaging/ ultrasound‑fusion biopsy for the diagnosis of prostate cancer. BJU Int 2015; 116: 873 25. Junker D, Schäfer G, Edlinger M, et al. Evaluation of the PI‑RADS scoring system for classifying mpMRI findings in men with suspicion of prostate cancer. BioMed Research International 2013; 2013: 252939. 26. Ghai S, Haider MA. Multiparametric‑MRI in diagnosis of prostate cancer. Indian Journal of Urology: IJU: Journal of the Urological Society of India 2015; 31(3): 194–201. 27. Mowatt G, Scotland G, Boachie C, et al. The diagnostic accuracy and cost‑effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation. Health Technol Assess (Winchester, England) 2013; 17: 1–281. Vii.xix. 28. Kudláčková Š, Král M, Kurfürstová D, et al. Role multiparametrické magnetické rezonance v režimu active surveillance karcinomu prostaty. Ces Urol 2017; 21(3): 225–230. 29. Pivovarčíková, K, Branžovský J, Bauleth K, et al. Radikální prostatektomie – analýza 191 případů vy‑ šetřovaných metodikou celoplošných řezů (whole‑Mount Section). Ces Urol 2014; 18(1): 26–32. 30. Kudláčková Š, Záťura F, et al. Cílená biopsie prostaty pomocí magnetické rezonance – 1. část. Interní Med. 2017; 18(2): 69–72.